Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
about
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisMethods to find out the expression of activated genesUnderstanding the cognitive impact of the contraceptive estrogen Ethinyl Estradiol: tonic and cyclic administration impairs memory, and performance correlates with basal forebrain cholinergic system integrity.Ramifications of four concurrent thrombophilic mutations and one hypofibrinolytic mutationPharmacology of estrogens and progestogens: influence of different routes of administrationPrevention and treatment of venous thromboembolism during HRT: current perspectives.Hormones and pregnancy: thromboembolic risks for women.Menopausal hormone therapy and venous thromboembolism.The effects of obesity on venous thromboembolism: A review.Clinical appraisal of the Women's Health Initiative.Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches.Effects of hormone treatment on hemostasis variables.Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women.Postmenopausal hormone therapy and the risk of venous thromboembolism.Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies.Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkersWhat's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone.Estrogen and progestogen effect on venous thromboembolism in menopausal women.Benefits and risks during HRT: main safety issue breast cancer.Transdermal estrogens in the changing landscape of hormone replacement therapy.Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women.The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy.Transdermal hormone therapy and the risk of stroke and venous thrombosis.Role of inflammatory cytokines in the effect of estradiol on atheroma.Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study.
P2860
Q24647720-23B0AB50-9361-4D0B-B56E-44295EE98404Q24804002-7992F829-8D19-474E-9E94-55EA0E4FFFC2Q27304411-B77A8593-197A-4EC9-B6C4-D1F4A964B9D2Q28171246-7D84FF80-FDF8-469F-9060-39000FBDCAB1Q28268346-8BC01EDE-37C7-4932-8664-FE02E28BF1FCQ34140721-7F67487B-6D97-4198-B23D-4F8A31E4E4ACQ35852845-3D11541E-FE99-42E7-81C4-FEC5E7C19572Q35903637-781F2867-C7D3-4588-9E2C-A95B94A58DD1Q35904699-BE0BE6A7-08C9-47D2-90E2-64FB5311203FQ36072505-9D0CDCC3-9300-4825-9B99-8A685B03359BQ36723824-BA87A438-1AE0-462C-9C72-D62517F76048Q36946786-FAB26154-B2B3-455C-B184-95A0C808573AQ37223211-D674C116-52D3-419E-BC65-5DA49132CF54Q37223479-37D10D53-74FE-4AB4-9C85-CD27B924AADCQ37338824-5908C2D0-3D91-41E6-A2ED-202CD9BA5B92Q37385612-1C947A5D-CFA9-46D5-81EF-1EA97CFF2234Q37727617-2E690FD3-A96D-4B93-830A-9479B2FDF64AQ37995320-BBF8FC43-D1C0-424A-BED1-8D6D0E77DA2AQ37995321-4B10388C-4B08-42B3-A40C-83BB6E819192Q38011781-CB5E19FD-476B-4DF9-93FD-DA9A50826416Q38471535-5E5FCABA-EF5C-4AFA-B2AE-DEB8714B9A47Q38765828-3F8CA13C-9F0B-45B1-8FE8-8AD3B087727AQ38946055-FAD1008D-8EAE-464C-B337-1973D5D101E8Q39027448-4DBA1705-3274-4B63-BABD-5A87AEEEEA77Q39347912-638033D1-9E69-434E-B826-3FDE71BB99C6Q40439101-2419AC5F-BF30-4DC8-BEDC-201A4F399B34Q42167610-6F24A5BB-5BC0-49E1-B2F5-206BD1EA0B43Q43018685-D5F9921D-37D4-4E02-9664-294887BA804BQ43494612-B6D00F70-827D-4FCA-A4E1-499232C68CA3Q46727875-3950C13B-F17F-4534-A94E-E8C557B46A98Q46832277-E1987A70-5D3E-4A6C-9FA8-24F213101993Q46899634-1E0F197A-A20E-4410-8737-98C439EC562B
P2860
Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of oral and transdermal ...... study in postmenopausal women.
@en
Effect of oral and transdermal ...... study in postmenopausal women.
@nl
type
label
Effect of oral and transdermal ...... study in postmenopausal women.
@en
Effect of oral and transdermal ...... study in postmenopausal women.
@nl
prefLabel
Effect of oral and transdermal ...... study in postmenopausal women.
@en
Effect of oral and transdermal ...... study in postmenopausal women.
@nl
P2093
P1476
Effect of oral and transdermal ...... study in postmenopausal women.
@en
P2093
Jan Rosing
L G D Thomassen
M Christella
Marinka S Post
Marius J van der Mooren
Peter Kenemans
W Marchien van Baal
P304
P356
10.1161/01.ATV.0000074146.36646.C8
P407
P577
2003-05-01T00:00:00Z